These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 23542636)

  • 21. Comparison of cryptococcal antigenemia between antiretroviral naïve and antiretroviral experienced HIV positive patients at two hospitals in Ethiopia.
    Beyene T; Woldeamanuel Y; Asrat D; Ayana G; Boulware DR
    PLoS One; 2013; 8(10):e75585. PubMed ID: 24124498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of cryptococcal antigenuria at initial HIV diagnosis in KwaZulu-Natal.
    Drain PK; Kleene JM; Coleman SM; Losina E; Katz JN; Giddy J; Ross D; Freedberg KA; Bassett IV
    HIV Med; 2015 Nov; 16(10):640-4. PubMed ID: 25958770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum Cryptococcal Antigen Testing in Immunosuppressed HIV-positive Children and Adolescents.
    Zuma P; Ramsamy Y; Mlisana K; Archary M
    Pediatr Infect Dis J; 2020 Mar; 39(3):217-220. PubMed ID: 31725553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High prevalence of Cryptococcal antigenemia using a finger-prick lateral flow assay in individuals with advanced HIV disease in Santarém Municipality, Brazilian Amazon Basin.
    Assy JGPL; Said RDC; Pinheiro OC; Brandão ADS; Boulware DR; França FOS; Vidal JE
    Med Mycol; 2021 Sep; 59(9):909-915. PubMed ID: 33908611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/µL: A Stepped-Wedge, Cluster-Randomized Trial.
    Meya DB; Kiragga AN; Nalintya E; Morawski BM; Rajasingham R; Park BJ; Mubiru A; Kaplan JE; Manabe YC; Boulware DR
    J Acquir Immune Defic Syndr; 2019 Feb; 80(2):182-189. PubMed ID: 30399034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cryptococcal antigen carriage among HIV infected children aged 6 months to 15 years at Laquintinie Hospital in Douala.
    Kalla GCM; Mboumnyemb JF; Assob JCN; Ehouzou Mandeng MN; Kamgaing Noubi N; Okomo Assoumou MC; Mbopi-Keou FX; Monebenimp F
    PLoS One; 2021; 16(7):e0253781. PubMed ID: 34242263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Underlying Cryptococcal Diseases and the Correlation With Serum Cryptococcal Antigen Titers in Hospitalized HIV-Infected Patients Screened Positive for Cryptococcal Antigenemia.
    Xu M; Peng Z; Xu C; Chen Y; Cheng J; Chi Y; Wei H; Chen W; Hu Z
    Front Cell Infect Microbiol; 2020; 10():170. PubMed ID: 32391288
    [No Abstract]   [Full Text] [Related]  

  • 28. Point-of-Care Testing for Cryptococcal Disease Among Hospitalized Human Immunodeficiency Virus-Infected Adults in Ethiopia.
    Mamuye AT; Bornstein E; Temesgen O; Blumberg HM; Kempker RR
    Am J Trop Med Hyg; 2016 Oct; 95(4):786-792. PubMed ID: 27527636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cryptococcal antigen positivity combined with the percentage of HIV-seropositive samples with CD4 counts <100 cells/μl identifies districts in South Africa with advanced burden of disease.
    Coetzee LM; Cassim N; Sriruttan C; Mhlanga M; Govender NP; Glencross DK
    PLoS One; 2018; 13(6):e0198993. PubMed ID: 29894509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of a point-of-care immunoassay test kit 'StrongStep' for cryptococcal antigen detection.
    Mpoza E; Mukaremera L; Kundura DA; Akampurira A; Luggya T; Tadeo KK; Pastick KA; Bridge SC; Tugume L; Kiggundu R; Musubire AK; Williams DA; Muzoora C; Nalintya E; Rajasingham R; Rhein J; Boulware DR; Meya DB; Abassi M
    PLoS One; 2018; 13(1):e0190652. PubMed ID: 29304090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Antibody Immunity With Cryptococcal Antigenemia and Mortality in a South African Cohort With Advanced Human Immunodeficiency Virus Disease.
    Yoon H; Wake RM; Nakouzi AS; Wang T; Agalliu I; Tiemessen CT; Govender NP; Jarvis JN; Harrison TS; Pirofski LA
    Clin Infect Dis; 2023 Feb; 76(4):649-657. PubMed ID: 35915964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of fingerstick cryptococcal antigen lateral flow assay in HIV-infected persons: a diagnostic accuracy study.
    Williams DA; Kiiza T; Kwizera R; Kiggundu R; Velamakanni S; Meya DB; Rhein J; Boulware DR
    Clin Infect Dis; 2015 Aug; 61(3):464-7. PubMed ID: 25838287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of cryptococcal antigenemia and cost-effectiveness of a cryptococcal antigen screening program--Vietnam.
    Smith RM; Nguyen TA; Ha HT; Thang PH; Thuy C; Lien TX; Bui HT; Le TH; Struminger B; McConnell MS; Fanfair RN; Park BJ; Harris JR
    PLoS One; 2013; 8(4):e62213. PubMed ID: 23626792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prevalence of cryptococcal antigenemia in newly diagnosed HIV patients in a Southwest London cohort.
    Patel S; Shin GY; Wijewardana I; Vitharana SR; Cormack I; Pakianathan M; Harrison TS; Bicanic T
    J Infect; 2013 Jan; 66(1):75-9. PubMed ID: 23046967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prevalence and clinical course of HIV-associated pulmonary cryptococcosis in Uganda.
    Deok-jong Yoo S; Worodria W; Davis JL; Cattamanchi A; den Boon S; Kyeyune R; Kisembo H; Huang L
    J Acquir Immune Defic Syndr; 2010 Jul; 54(3):269-74. PubMed ID: 20150818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of screening and treatment of cryptococcal antigenaemia among HIV-infected persons in Soweto, South Africa.
    Govender NP; Roy M; Mendes JF; Zulu TG; Chiller TM; Karstaedt AS
    HIV Med; 2015 Sep; 16(8):468-76. PubMed ID: 25689352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cryptococcal antigen prevalence in HIV-infected Tanzanians: a cross-sectional study and evaluation of a point-of-care lateral flow assay.
    Rugemalila J; Maro VP; Kapanda G; Ndaro AJ; Jarvis JN
    Trop Med Int Health; 2013 Sep; 18(9):1075-1079. PubMed ID: 23937699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cryptococcal Antigenemia in Human Immunodeficiency Virus Antiretroviral Therapy-Experienced Ugandans With Virologic Failure.
    Mpoza E; Rajasingham R; Tugume L; Rhein J; Nabaggala MS; Ssewanyana I; Nyegenye W; Kushemererwa GE; Mulema V; Kalamya J; Kiyaga C; Kabanda J; Ssali M; Boulware DR; Meya DB
    Clin Infect Dis; 2020 Oct; 71(7):1726-1731. PubMed ID: 31679007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD4 Cell Count Threshold for Cryptococcal Antigen Screening of HIV-Infected Individuals: A Systematic Review and Meta-analysis.
    Ford N; Shubber Z; Jarvis JN; Chiller T; Greene G; Migone C; Vitoria M; Doherty M; Meintjes G
    Clin Infect Dis; 2018 Mar; 66(suppl_2):S152-S159. PubMed ID: 29514236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients.
    Micol R; Lortholary O; Sar B; Laureillard D; Ngeth C; Dousset JP; Chanroeun H; Ferradini L; Guerin PJ; Dromer F; Fontanet A
    J Acquir Immune Defic Syndr; 2007 Aug; 45(5):555-9. PubMed ID: 17577124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.